We specialize in growth capital, with a focus on China-related investments in healthcare, technology (including deep tech) and consumer. We are dedicated to investing in high quality growth companies and assisting in unlocking the full intrinsic value of those companies.
For the past decade, we have partnered with visionary founders of iconic companies and continue to invest in entrepreneurs with bold ideas, proven track records, teams of capable talents and unique business models focused on expediting growth in China.
Our consciously-cultivated ecosystem comprising investment managers with complementary and synergistic coverage to VMS, provides a platform for cross-fertilization in deal sourcing and other areas, which in turn create additional value to investors and other stakeholders.
Invest throughout the entire healthcare cycle, covering global therapeutics, diagnostics, and healthcare services with a unique China angle.
Focus on healthcare companies that tap into the unmet clinical demand with clinically validated Proof-of-Concept, products and solutions and favourable economics. The management of these companies must demonstrate excellent capabilities in terms of R&D, clinical as well as commercial knowledge.
Identify leaders who leverage technology to create value in their targeted industries with solid track records and clear business vision to grow their companies.
Leading players with potential to be the next “unicorn” in the competitive market, with resilient management teams, attractive unit economics and business models.
Identify companies with disruptive IP-protected technology in the post-PoC stage, and are validated by reputable strategic investors. They should also fall within the core sectors in our own eco-system.
The above only shows selected portfolio companies VMS invested in.